Ready 8-Ks
3
Latest filing
August 12, 2026, 4:20 PM ET
Top materiality
0.85
Event mix
earnings ×2 · other_material ×1
Sentiment
2 pos · 0 neg · 1 neu
Recent 8-K filings for KLRA
Highest-materiality recent filing
Kailera Therapeutics closes IPO raising $718.8M; issues 44.9M shares at $16.00
- Closed IPO of 44,921,875 shares at $16.00 per share, including full exercise of underwriters' option for 5,859,375 additional shares.
- Gross proceeds of $718.8 million before underwriting discounts and offering expenses.
-
Kailera Q2 net loss widens to $111.3M; cash $1.17B funds into mid-2028
Net loss $111.3M in Q2 2026 vs $28.9M in Q2 2025; R&D expense $101.1M (up from $19.5M).
-
Kailera Q1 net loss $78.9M; advances obesity pipeline with Phase 3 start and positive data
Net loss of $78.9M in Q1 2026 vs $18.0M in Q1 2025; R&D expenses rose to $70.9M from $10.1M.
-
Kailera Therapeutics closes IPO raising $718.8M; issues 44.9M shares at $16.00
Closed IPO of 44,921,875 shares at $16.00 per share, including full exercise of underwriters' option for 5,859,375 additional shares.
Materiality & sentiment trend
Max materiality 0.85 · Median 0.75 · Most common event earnings